EGFR and prostate cancer: Overexpression of the epidermal growth factor receptor (EGFR) in primary tumors of prostate cancer and in high-grade gliomas, such as glioblastoma, often correlates with a poorer prognosis [15,16,17,18,19,20,21,22].